VR Logo

Astrazeneca Pharma India Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

37 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1979

Chairman: Narayan K Seshadri

Managing Director: Gagandeep Singh Bedi

Group: Astrazeneca Pharma India - MNC

Listing: NSE: ASTRAZEN, BSE: 506820

Headquarters: Bengaluru, Karnataka

Website: www.astrazenecaindia.com

Key Facts

Market cap: R 6,221.13 Cr

Revenue (TTM): R 818.54 Cr

Earnings (TTM): R 74.85 Cr

Cash: R 173.30 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,570.00 - 2,931.85

Face value: R2.00

Shares outstanding: 2,50,00,000

Stock Performance

Time Period Astrazeneca Pharma India * *
YTD-4.79----
1 month-10.52----
3 months9.34----
1 Year55.30----
3 Years36.56----
5 Years23.48----
10 Years10.96----
As on 20-Jan-2020 *As on
Year Astrazeneca Pharma India S&P BSE Small Cap S&P BSE Healthcare
201981.26-6.85-3.55
201824.22-23.41-5.89
201726.0059.640.49
2016-26.411.77-12.88
201543.316.7615.06
20142.9469.2447.43
2013-37.81-11.2322.55